Literature DB >> 8037023

Understanding and optimizing use of contrast material for CT of the liver.

R L Baron1.   

Abstract

Improvements in CT technology have dramatically increased our ability to detect and diagnose liver abnormalities, particularly neoplastic disease. Because of the high prevalence of liver disease in patients referred for abdominal CT examinations, contrast administration and scanning techniques are usually optimized for detection of liver disease on abdominal CT scans. A wide variety of contrast techniques can be used to evaluate the liver, and it is important to understand both the rationale behind each technique and the impact on the quality of the examination when one deviates from these techniques. In addition, the timing of contrast administration and scan acquisition has become critical, and improper timing can cause lesions that are easily visualized to be obscured. This article reviews principles of lesion detection and the effects of various contrast techniques on lesion visualization.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8037023     DOI: 10.2214/ajr.163.2.8037023

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  32 in total

1.  Value of lipiodol computed tomography and digital subtraction angiography in the era of helical biphasic computed tomography as preoperative assessment of hepatocellular carcinoma.

Authors:  A Nakayama; H Imamura; Y Matsuyama; H Kitamura; S Miwa; A Kobayashi; S Miyagawa ; S Kawasaki
Journal:  Ann Surg       Date:  2001-07       Impact factor: 12.969

2.  Standardisation of liver MDCT by tracking liver parenchyma enhancement to trigger imaging.

Authors:  H Brodoefel; A Tognolini; G A Zamboni; S Gourtsoyianni; C D Claussen; V Raptopoulos
Journal:  Eur Radiol       Date:  2011-11-05       Impact factor: 5.315

3.  Reduction of the unnecessary dose from the over-range area with a spiral dynamic z-collimator: comparison of beam pitch and detector coverage with 128-detector row CT.

Authors:  Takashi Shirasaka; Yoshinori Funama; Mutsukazu Hayashi; Shinichi Awamoto; Masatoshi Kondo; Yasuhiko Nakamura; Masamitsu Hatakenaka; Hiroshi Honda
Journal:  Radiol Phys Technol       Date:  2011-10-15

4.  [Multidetector computed tomography of the liver].

Authors:  W Schima; C Kulinna; A Ba-Ssalamah; T Grünberger
Journal:  Radiologe       Date:  2005-01       Impact factor: 0.635

5.  Detection of malignant primary hepatic neoplasms with gadobenate dimeglumine (Gd-BOPTA) enhanced T1-weighted hepatocyte phase MR imaging: results of off-site blinded review in a phase-II multicenter trial.

Authors:  C S Peña; S Saini; R L Baron; B A Hamm; G Morana; R Caudana; A Giovagnoni; A Villa; A Carriero; D Mathieu; M W Bourne; M A Kirchin; G Pirovano; A Spinazzi
Journal:  Korean J Radiol       Date:  2001 Oct-Dec       Impact factor: 3.500

6.  Efficacy of double arterial phase dynamic magnetic resonance imaging with the sensitivity encoding technique versus dynamic multidetector-row helical computed tomography for detecting hypervascular hepatocellular carcinoma.

Authors:  Seishi Kumano; Masahiko Uemura; Toyoaki Haraikawa; Masaaki Hirata; Keiichi Kikuchi; Tonsok Kim; Masahiro Okada; Teruhito Mochizuki; Takamichi Murakami
Journal:  Jpn J Radiol       Date:  2009-07-22       Impact factor: 2.374

Review 7.  [Multidetector computed tomography in abdominal emergencies].

Authors:  N Zorger; A G Schreyer
Journal:  Radiologe       Date:  2009-06       Impact factor: 0.635

8.  Automatic annotation of radiological observations in liver CT images.

Authors:  Francisco Gimenez; Jiajing Xu; Yi Liu; Tiffany Liu; Christopher Beaulieu; Daniel Rubin; Sandy Napel
Journal:  AMIA Annu Symp Proc       Date:  2012-11-03

9.  Noise-reducing algorithms do not necessarily provide superior dose optimisation for hepatic lesion detection with multidetector CT.

Authors:  K L Dobeli; S J Lewis; S R Meikle; D L Thiele; P C Brennan
Journal:  Br J Radiol       Date:  2013-02-07       Impact factor: 3.039

Review 10.  Imaging of metastases to the liver.

Authors:  A E Mahfouz; B Hamm; D Mathieu
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.